Gates Foundation WRF Capital Academic & Research Institutions Non- Dilutive Funding Syndication Partners Harvard Medical School Lydian Neurosciences Lewis Cantley Uniformed Services University Strategic Partnerships Rodeo Therapeutics Venture Capital $12.3 Million NIDA Grant Tachi Yamada, M.D. Neuroscience & Neurology Sundar Kodiyalam Dana Farber Cancer Capital- efficiency Exceptional Track Record Leroy Hood, M.D., Ph.D. MD Anderson Cancer Center CSAB Members? Apogen Biotechnologies ARCH Venture Partners Seattle Office Employees Reviewed > 4,000 Opportunities UT Southwestern $3.375 Billion Exit San Diego Office CPRIT Jan Lundberg, Ph.D. Top-tier Investors Lodo Therapeutics high-quality, cutting edge life science companies Eli Lilly Operating Partners? Divestitures (BARDA) – on updated slide deck Singapore Office University of Minnesota Columbia University Proniras Weill Cornell Medicine Petra Pharma Gene Yeo, Ph.D. $1 Billion Genentech Collaboration The Rockefeller University Penn State The Rockefeller University 150+ Years’ Experience Alexandria Venture Investments Magnolia Neurosciences Lodo Therapeutics Diversity 58.43% IRR Weill Cornell Medicine Syndication New York Office Temasek Scientists & Technology Developers 2.85 DVPI Infectious Disease, Oncology, Microbiome Turn- Key Facilities Targeted Therapeutic (Asset) Financing Advisory & Corporate Boards Scientific Expertise Steve Gillis, Ph.D. Oncology 1.02 DPI Case Western Reserve UT Southwestern Medical Center Pfizer Ventures AI & Machine Learning Fund I net IRR of 58.4% Entrepreneurs 2014 Top- quartile Ranked Abbvie Corporate Spinouts Rodeo Therapeutics Substantial Exit History WuXi PharmaTech Gates Foundation Bruce L.A. Carter, Ph.D. Gates Foundation WRF Capital Academic & Research Institutions Non- Dilutive Funding Syndication Partners Harvard Medical School Lydian Neurosciences Lewis Cantley Uniformed Services University Strategic Partnerships Rodeo Therapeutics Venture Capital $12.3 Million NIDA Grant Tachi Yamada, M.D. Neuroscience & Neurology Sundar Kodiyalam Dana Farber Cancer Capital- efficiency Exceptional Track Record Leroy Hood, M.D., Ph.D. MD Anderson Cancer Center CSAB Members? Apogen Biotechnologies ARCH Venture Partners Seattle Office Employees Reviewed > 4,000 Opportunities UT Southwestern $3.375 Billion Exit San Diego Office CPRIT Jan Lundberg, Ph.D. Top-tier Investors Lodo Therapeutics high-quality, cutting edge life science companies Eli Lilly Operating Partners? Divestitures (BARDA) – on updated slide deck Singapore Office University of Minnesota Columbia University Proniras Weill Cornell Medicine Petra Pharma Gene Yeo, Ph.D. $1 Billion Genentech Collaboration The Rockefeller University Penn State The Rockefeller University 150+ Years’ Experience Alexandria Venture Investments Magnolia Neurosciences Lodo Therapeutics Diversity 58.43% IRR Weill Cornell Medicine Syndication New York Office Temasek Scientists & Technology Developers 2.85 DVPI Infectious Disease, Oncology, Microbiome Turn- Key Facilities Targeted Therapeutic (Asset) Financing Advisory & Corporate Boards Scientific Expertise Steve Gillis, Ph.D. Oncology 1.02 DPI Case Western Reserve UT Southwestern Medical Center Pfizer Ventures AI & Machine Learning Fund I net IRR of 58.4% Entrepreneurs 2014 Top- quartile Ranked Abbvie Corporate Spinouts Rodeo Therapeutics Substantial Exit History WuXi PharmaTech Gates Foundation Bruce L.A. Carter, Ph.D.
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Gates Foundation
WRF Capital
Academic & Research Institutions
Non-Dilutive Funding
Syndication Partners
Harvard Medical School
Lydian Neurosciences
Lewis Cantley
Uniformed Services University
Strategic Partnerships
Rodeo Therapeutics
Venture Capital
$12.3 Million NIDA Grant
Tachi Yamada, M.D.
Neuroscience & Neurology
Sundar Kodiyalam
Dana Farber Cancer
Capital-efficiency
Exceptional Track Record
Leroy Hood, M.D., Ph.D.
MD Anderson Cancer Center
CSAB Members?
Apogen Biotechnologies
ARCH Venture Partners
Seattle Office
Employees
Reviewed > 4,000 Opportunities
UT Southwestern
$3.375 Billion Exit
San Diego Office
CPRIT
Jan Lundberg, Ph.D.
Top-tier Investors
Lodo Therapeutics
high-quality, cutting edge life science companies
Eli Lilly
Operating Partners?
Divestitures
(BARDA) – on updated slide deck
Singapore Office
University of Minnesota
Columbia University
Proniras
Weill Cornell Medicine
Petra Pharma
Gene Yeo, Ph.D.
$1 Billion Genentech Collaboration
The Rockefeller University
Penn State
The Rockefeller University
150+ Years’ Experience
Alexandria Venture Investments
Magnolia Neurosciences
Lodo Therapeutics
Diversity
58.43% IRR
Weill Cornell Medicine
Syndication
New York Office
Temasek
Scientists & Technology Developers
2.85 DVPI
Infectious Disease, Oncology, Microbiome
Turn-Key Facilities
Targeted Therapeutic (Asset) Financing
Advisory & Corporate Boards
Scientific Expertise
Steve Gillis, Ph.D.
Oncology
1.02 DPI
Case Western Reserve
UT Southwestern Medical Center
Pfizer Ventures
AI & Machine Learning
Fund I net IRR of 58.4%
Entrepreneurs
2014 Top-quartile Ranked
Abbvie
Corporate Spinouts
Rodeo Therapeutics
Substantial Exit History
WuXi PharmaTech
Gates Foundation
Bruce L.A. Carter, Ph.D.